ADC Therapeutics SA has granted options to purchase a total of 308,000 common shares to seven new employees. The options will vest 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments over the following three years, becoming fully vested after four years, contingent on continued employment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADC Therapeutics SA published the original content used to generate this news brief on February 02, 2026, and is solely responsible for the information contained therein.